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Population ageing is progressing at a rapid pace in the West, with 
increases in the proportion of people aged 65 years and older 
reflected in patients with head and neck cancer (HNC) (Netherlands 
Comprehensive Cancer Organisation (IKNL©) (2017). Defining the 
optimal treatment plan for each of these patients is challenging 
because of the need for intensive treatment in a population that 
tends to be considered unhealthy and vulnerable (Porceddu & 
Haddad, 2017).
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Abstract
Objective: We aimed to compare frailty status between patients with head and neck 
cancer (HNC) and other solid malignancies.
Methods: Data collection was prospective, and the following were compared between 




odds ratios (ORs) with their 95% confidence intervals (95% CIs) were estimated.
Results: In	total,	242	patients	with	HNC	and	180	with	other	oncology	diagnoses	were	







Conclusion: Patients with HNC appear to be frailer than patients with other solid 
malignancies despite comparable levels of comorbidity.
K E Y W O R D S
frail	elderly,	frailty,	geriatric	assessment,	geriatric	oncology,	head	and	neck	cancer,	quality	of	
life
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Chronological age has been established as a highly relevant fac‐
tor	 in	clinical	decision‐making	 (Derks,	de	Leeuw,	&	Hordijk,	2005).	
Consequently,	elderly	HNC	patients	more	often	receive	non‐conven‐
tional or less intensive treatment than their younger peers, despite 
a lack of evidence for chronological age being a negative prognos‐
tic	factor	for	adverse	outcomes	(Halmos	et	al.,	2018;	Teymoortash,	
Ferlito,	 &	 Halmos,	 2016;	 van	 der	 Schroeff,	 Derks,	 Hordijk,	 &	 de	
Leeuw,	2007).	Although	comorbidity	and	age	are	often	considered	
when making decisions, research in patients with laryngeal cancer 
has shown that age did not correlate with higher complication rates 
and that comorbidity in elderly was not associated with increased 
complication	rates	 (T.	T.	A.	Peters	et	al.,	2011).	Therefore,	 it	might	
be reasonable to consider a patient's biological age rather than his 
or her chronological age and comorbidities when making treatment 
decisions.
Frailty	 is	 a	 well‐studied	 concept	 that	 describes	 a	 biological	
state of increased susceptibility to adverse effects after exposure 
to a stressful event (Clegg, Young, Iliffe, Rikkert, & Rockwood, 
2013; Porceddu & Haddad, 2017). The Comprehensive Geriatric 
Assessment	 (CGA)	 is	 the	 current	 gold	 standard	 for	 identifying	
frail patients through multidimensional evaluation of a patient's 
functional status, comorbidities, cognition, psychological state, 
social support, nutritional status and polypharmacy (Extermann 
&	 Hurria,	 2007).	 However,	 the	 CGA	 is	 time‐consuming,	 which	
has led to shorter frailty screening tools being developed. These 
tools	can	be	used	in	a	“two‐step	approach”	to	select	eligible	pa‐
tients	 for	 a	 CGA.	We	 considered	 that	 patients	 with	 HNC	 may	
have higher biological ages and greater frailty due to relatively 
unhealthy lifestyles compared with patients with other solid ma‐
lignancies. This situation may then be further compounded by 
the higher risk of malnutrition due to dysphagia that results from 
tumour localisation in the upper aerodigestive tract (Derks et al., 
2005;	Noor	et	al.,	2018).	To	date,	this	assumption	has	not	been	
tested.
In the present study, we aimed to compare geriatric assessment 
data between patients with HNC and those with other solid malig‐
nancies in one study, using similar instruments. The present study 
builds on and develops existing knowledge, confirming previously 
held assumptions of frailty, thereby emphasising the importance of 
awareness of this state in patients with HNC. We anticipate that our 
findings	will	help	to	inform	decisions	about	treatment	and	pre‐treat‐
ment optimisation.
2  | MATERIAL AND METHODS
2.1 | Study design
We compared two cohorts in this observational study: an HNC co‐
hort	and	a	surgical	oncology	 (SO)	cohort.	The	data	of	each	cohort	
were collected prospectively during the diagnostic process, before 
any decisions were made about treatment, and focused on patient 
characteristics,	 disease	 characteristics,	 frailty	 and	 quality	 of	 life	
(QoL).
The HNC cohort comprised a consecutive series of patients 
treated	for	primary	squamous	cell	carcinomas	of	the	oral	cavity,	oro‐
pharynx, hypopharynx, larynx, nasal cavity and paranasal sinuses at 
the	University	Medical	Center	Groningen	(UMCG)	between	October	
2014	 and	 October	 2017	 who	 were	 registered	 in	 the	 OncoLifeS	
data‐biobank.	This	data‐biobank	is	managed	by	UMCG	and	includes	









Data for patients with HNC were gathered as part of a major pro‐








hort provided written informed consent.
2.3 | Patient and disease characteristics
The patient and disease characteristics available for each cohort are 
presented in Table 1. Intoxication data were not available for the 
SO	cohort,	so	they	are	not	provided.	In	both	cohorts,	tumours	were	
staged according to the 7th edition of the TNM classification sys‐
tem	of	the	American	Joint	Committee	on	Cancer	and	the	Union	for	
International	Cancer	Control	(American	Joint	Committee	on	Cancer	









2.4 | Frailty, geriatric assessment, and QoL 
questionnaires and assessments
The	frailty,	geriatric	assessment	and	QoL	measures	available	in	each	
cohort are presented in Table 2. The data set used the Groningen 
Frailty Indicator (GFI) as a screening tool for frailty (L. L. Peters, 
Boter,	Buskens,	&	Slaets,	2012;	Schuurmans,	Steverink,	Lindenberg,	
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Frieswijk,	 &	 Slaets,	 2004),	 the	 Mini‐Mental	 State	 Examination	
(MMSE)	as	a	measure	for	cognition	(van	der	Cammen,	van	Harskamp,	




















(n = 180) OR (95% CI) p‐value
Age	(years)    .57
≤54 35	(14.5%) 33	(18.3%) 1  
55–74 158	(65.3%) 112 (62.2%) 1.33	(0.78–2.27) .30
≥75 49	(20.2%) 35	(19.4%) 1.32	(0.69–2.51) .40
Sex     
Female 66 (27.3%) 77	(42.8%) 1
Male 176 (72.7%) 103 (57.2%) 1.99	(1.32–3.00)  .001
BMI     
<25 130 (53.9%) 59	(34.3%) 1  
≥25 111	(46.1%) 113 (65.7%) 0.45	(0.30–0.67) <.001
Missing 1 8   
Relationship status     
In a relationship 153 (66.2%) 129 (72.9%) 1  
Single 78	(33.8%) 48	(27.1%) 1.37	(0.89–2.10) .15
Missing 11 3   
Education    
Primary school 36 (17.1%) 24	(13.6%) 1  
Secondary	and	
tertiary school
174	(82.9%) 153	(86.4%) 0.76	(0.43–1.33)  .33
Missing 32 3   
CCI score     
<3 224	(92.6%) 153	(86.9%) 1  
≥3 18	(7.4%) 23 (13.1%) 0.54	(0.28–1.02) .06
Missing 0 4   
Tumour stage     
Early	stage	(I–II) 78	(32.2%) 53 (37.1%) 1  
Advanced	stage	
(III–IV)
164	(67.8%) 90 (62.9%) 1.24	(0.80–1.91) .33
Missing 0 37   
Treatment intention     
Curative 220 (90.9%) 157 (91.3%) 1  
Palliative 22 (9.1%) 15	(8.7%) 1.05	(0.53–2.08) .90
Missing 0 8   
Note: Statistical	test:	univariate	logistic	regression	analysis.	Being	member	of	the	HNC	cohort	is	




TA B L E  1   Patient and disease 
characteristics	in	the	HNC	and	SO	cohorts	
(n	=	422;	n	[%])
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the EORTC, with higher scores indicating a high degree of functioning 
(Aaronson	et	al.,	1993;	Fayers	et	al.,	2001;	Pottel	et	al.,	2014).
2.5 | Statistical analysis
To compare the two cohorts, patients were stratified by cohort in 
univariate logistic regression analyses. The diagnosis (being in the 
HNC	cohort	vs.	being	in	the	SO	cohort)	was	considered	the	depend‐
ent	variable,	and	the	patient,	disease,	frailty	and	QoL	characteristics	
were considered the independent variables. Odds ratios (ORs) and 
95% confidence intervals (95% CIs) were estimated on this basis. 
Next, multivariate logistic regression analysis with backward selec‐






(n = 180) OR (95% CI) p‐value
GFI
Non‐frail 159	(67.4%) 140	(78.2%) 1  
Frail 77 (32.6%) 39	(21.8%) 1.74	(1.11–2.71) .02
Missing 6 2   
ADL
Independent 223	(94.1%) 164	(94.8%) 1  
 (Moderately) 
dependent
14	(5.9%) 9 (5.2%) 1.14	(0.48–2.71) .76
Missing 5 7   
IADL
No restrictions 180	(74.4%) 141	(81.5%) 1  
Restrictions 62 (25.6%) 32	(18.5%) 1.52	(0.94–2.45) .09




205	(85.4%) 176	(98.9%) 1  
Restricted cognitive 
functioning
35	(14.6%) 2 (1.1%) 15.02 
(3.56–63.36)
<.001
Missing 2 2   
TUG
Good mobility 211 (93.0%) 162	(98.8%) 1  
Restricted mobility 16 (7.0%) 2 (1.2%) 6.14	(1.39–27.10) .02
Missing 15 16   
EORTC	QLQ‐C30a
Global	QoL	scale 70.35 ± 20.31 75.62	±	19.74 0.99	(0.98–1.00) .01
Functioning scales
Physical functioning 81.96	±	20.76 85.10	±	17.39 0.99	(0.98–1.00) .15
Role functioning 83.80	±	26.22 78.29	±	26.65 1.01	(1.00–1.02) .02
Emotional 
functioning
70.45	±	23.75 79.95 ± 19.27 0.98	(0.97–0.99) <.001
Cognitive 
functioning
90.70	±	15.58 84.67	±	19.12 1.02	(1.01–1.03) .001
Social	functioning 89.69	±	17.68 85.71	±	21.64 1.01	(1.00–1.02) .03
Note: Statistical	test:	univariate	logistic	regression	analysis.	Being	member	of	the	HNC	cohort	is	







amean ± SD. 
TA B L E  2   Frailty, geriatric assessment 
and	QoL	characteristics	in	the	HNC	
and	SO	cohorts	(n	=	422;	n (%), unless 
specified otherwise)
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p‐value	<	0.20	by	univariate	analysis	were	entered	in	the	model.	Age	
was always included in the multivariable model to allow proper ad‐
justment for this variable. To check for collinearity between the in‐




achieved if the p‐value	was	<	0.05.
3  | RESULTS
3.1 | Patient and disease characteristics
In	 total,	 422	 patients	 were	 included	 in	 the	 present	 study,	 with	





with	 high	 comorbidity	 scores	 (7.4%	 vs.	 13.1%;	 OR	 0.54,	 95%	 CI	
0.28–1.02;	 not	 significant).	 In	 the	 HNC	 cohort,	 5.4%	 of	 the	 pa‐
tients	had	a	body	mass	 index	 (BMI)	<18.5	kg/m2, whereas in the 
SO	cohort,	no	patients	were	underweight.	However,	we	observed	
no statistically significant differences in age, relationship status, 
education level, tumour stage or treatment intention between the 
two cohorts.









with	 a	mean	difference	of	5	points	 compared	with	 the	SO	cohort	
(OR	0.99,	95%	CI	0.98–1.00).	Patients	with	HNC	also	had	a	 lower	




functioning were higher in the HNC cohort.
3.3 | Multivariate analysis




fewer	overweight	 patients	 (OR	0.37,	 95%	CI	0.22–0.62).	Also,	 the	
HNC	cohort	had	worse	 scores	 than	 the	SO	cohort	 for	 the	MMSE	
(OR	20.03,	95%	CI	2.44–164.31)	and	TUG	(OR	11.56,	95%	CI	1.86–
71.68),	 as	well	 as	 for	global	QoL	 (OR	0.98,	95%	CI	0.97–1.00)	and	
emotional	functioning	(OR	0.96,	95%	CI	0.95–0.98).	By	contrast,	the	
HNC	cohort	had	better	role	functioning	(OR	1.03,	95%	CI	1.01–1.04)	
and	 cognitive	 functioning	 (OR	 1.04,	 95%	CI	 1.02–1.06)	 scores	 ac‐
cording	to	the	EORTC	QLQ–C30.	Collinearity	was	not	identified	be‐
tween the variables in the multivariate model.
4  | DISCUSSION
Despite a lack of direct evidence, it has often been stated that pa‐
tients with HNC are frailer than their peers with other solid malig‐
nancies, mainly due to their comparatively less healthy lifestyles. In 
the present study, we used multiple validated instruments to com‐
pare a cohort of patients with HNC and a cohort of patients with 
other solid malignancies. To our knowledge, no study to date has 
directly compared the frailty status of an HNC cohort with another 
SO	 cohort	 within	 one	 study	 in	 one	 centre,	 using	 similar	 geriatric	
Questionnaires/
assessments Goal Range Cut‐off value
Charlson Comorbidity Index 
(CCI)
Comorbidity n/a ≥3
Groningen Frailty Indicator 
(GFI)










Functional scale 0–7 ≤6:	restrictions	in	IADL
Timed	Up	and	Go	(TUG) Mobility 0–∞	s ≥20	s:	impaired	
mobility
EORTC	QLQ‐C30 Quality	of	life 0–100 n/a
TA B L E  3  Overview	of	questionnaires	
and	assessments	used,	with	their	cut‐off	
values
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assessment tools. The key finding of this research was that the HNC 
cohort had a significantly higher level of frailty, as measured by the 
GFI,	and	significantly	more	cognitive	(MMSE)	and	mobility	(TUG)	im‐
pairments. Moreover, despite comparable age and tumour stage be‐
tween	the	cohorts,	the	HNC	cohort	had	worse	global	QoL	(EORTC	
QLQ‐C30).	These	findings	emphasise	the	importance	of	awareness	
of frailty in HNC services.
Given that tobacco and alcohol use are the main risk factors for 
developing HNC, we expected that the HNC cohort would have 
an increased number of comorbidities (Maasland, Brandt, Kremer, 






Positive associations between comorbidity and frailty have 
also	 been	made	 in	 the	 literature.	Nieman	 et	 al.	 (2018)	 reported	
a significantly increased comorbidity rate in a frail HNC cohort 
(52.8%)	 compared	 with	 a	 non‐frail	 cohort	 (37.1%),	 which	 sup‐
ported earlier research (Fried, Ferrucci, Darer, Williamson, & 
Anderson,	 2004;	 Theou,	 Rockwood,	 Mitnitski,	 &	 Rockwood,	
2012). They even described a synergistic interaction in their co‐
hort	 between	 frailty	 and	 comorbidities,	with	 an	 increased	post‐
operative complication risk and longer hospitalisation in patients 
with	both	 factors	 (Nieman	et	al.,	2018).	By	contrast,	Fried	et	al.	
(2004)	reported	that	31.3%	of	frail	patients	in	their	cohort	had	no	
comorbidities. These data suggest that frailty has a distinct role, 
independent of comorbidity, which is supported by the results of 
the present study.
Although	 the	 CGA	 is	 the	 current	 gold	 standard	 for	measuring	
frailty, many screening instruments are available, albeit with varying 
degrees of success (Extermann & Hurria, 2007). For example, the 
predictive	value	of	the	GFI	in	oncology	cohorts	has	been	questioned	
in the literature. Hamaker et al. (2012) conducted a systematic re‐
view of the predictive value of several available instruments for 
demonstrating	 impairments	at	a	CGA	in	elderly	oncology	patients.	
They found that all tested frailty screening tools had rather poor 
discriminative powers. For the GFI, the sensitivity and specificity 
were	 39%–62%	 and	 69%–86%	 respectively.	 However,	 we	 were	
principally interested in identifying differences in frailty data rather 
than in using its predictive power. Given that the GFI has high con‐
struct validity and internal consistency, it should still have served as 
a useful tool for comparison of frailty data between the two cohorts 
(Metzelthin	 et	 al.,	 2010;	 Steverink,	 Slaets,	 Schuurmans,	&	 van	 Lis,	
2001).
In the present study, the prevalence of frailty was 32.6% and 
21.8%	 in	 the	HNC	 cohort	 and	 SO	 cohort	 respectively.	 Although	
frailty was more common in the HNC cohort, as expected, the 
prevalence in both cohorts was lower than previously described. 
In an HNC cohort (mucosal and cutaneous) of patients older than 
65	years,	we	previously	 reported	that	40%	of	patients	were	 frail	
(Bras	et	al.,	2015).	Also,	we	found	no	difference	in	frailty	between	
patients with HNC and those with skin cancer. In research by Plas 
et al. (2017), a comparable GFI frailty percentage of 35% was re‐
ported in a group of 219 patients aged 65 years and older who 





age, a lower frailty level could reasonably be expected in the pres‐
ent cohorts because we did not discriminate by age in the inclusion 
process	 (Clegg	et	al.,	2013).	Another	possible	explanation	 is	 that	
there	was	selection	bias	in	the	SO	cohort,	which	only	included	sur‐
gically treated patients. In this instance, it is possible that very frail 
patients were not considered suitable for surgical treatment and so 
were never referred.
Cognitive impairment is another factor associated with frailty, 
leading	 to	 the	 inclusion	 of	 cognitive	 tests	 in	 CGAs	 (Clegg	 et	 al.,	
2013;	 Fougere	 et	 al.,	 2017).	 Impaired	 pre‐treatment	 cognitive	
TA B L E  4  Patient,	disease,	geriatric	assessment	and	QoL	
characteristics	of	patients	in	the	HNC	and	SO	cohorts
Variables OR (95% CI) p‐value
Sex
Female 1
Male 3.50	(2.00–6.12)  <.001
BMI
<25 1
≥25 0.37	(0.22–0.62)  <.001
MMSE










Physical functioning 0.98	(0.96–1.00) .05
Role functioning 1.03	(1.01–1.04) .002
Emotional functioning 0.96	(0.95–0.98) <.001
Cognitive functioning 1.04	(1.02–1.06) <.001
Social	functioning 1.02	(1.00–1.04) .06
Note: Statistical	test:	multivariate	logistic	regression	analysis	adjusted	
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status has been found to be correlated with adverse health out‐
comes in patients with HNC and other cancers (van Deudekom et 
al.,	2017;	Libert	et	al.,	2016).	Several	studies	have	investigated	the	
degree of cognitive decline after oncologic surgery; however, the 
impact of any change remains inconclusive because both decreases 
and increases in cognitive function have regularly been observed 
(Extermann	&	Hurria,	2007;	Plas	et	al.,	2017).	 Impaired	MMSE	has	





selection bias was likely to have played a key role in this difference, 
with the inclusion of only surgically treated patients with other solid 
malignancies.
The	TUG	test	 is	a	simple,	quick	and	reliable	test	 for	evaluating	
mobility, and it is both sensitive and specific for identifying frailty 
in	 the	 elderly	 (Podsiadlo	 &	 Richardson,	 1991;	 Savva	 et	 al.,	 2013).	
Huisman	et	al.	 (2014)	 found	the	TUG	to	be	prognostic	of	surgery‐
related complications in geriatric oncology. In their prospective 
study, of 263 patients aged > 70 years who were surgically treated 
for a solid tumour, 16.0% had restricted mobility according to the 
TUG.	In	other	research,	Kenig	et	al.	(2015)	found	that	15%	of	their	
population also had restricted mobility. This is a greater proportion 
than	found	in	either	our	SO	cohort	(1.2%)	or	our	HNC	cohort	(7.0%),	
which	we	presume	is	because	of	the	10‐year	difference	 in	median	
ages (76 years vs. 66 and 67 years).
Although	 significant	 differences	 were	 found	 in	 cognition	 and	
mobility	between	the	two	cohorts,	the	95%	CIs	for	the	MMSE	and	
the	TUG	are	very	wide	in	both	the	uni‐	and	multivariate	logistic	re‐
gression analyses, due to the low number of patients with impaired 
cognition	and	restricted	mobility	in	the	SO	cohort.
A	 significant	 association	 between	 frailty	 and	 QoL	 has	 been	
demonstrated in patients with cancer and particularly in patients 






plies to the difference in emotional functioning that favoured the 
SO	cohort	and	to	the	differences	 in	cognitive	and	role	functioning	
that favoured the HNC cohort. Of note, cognitive functioning was 
higher in the HNC cohort when using this subjective scale, whereas 
the	MMSE	revealed	cognitive	 impairment.	Conflicting	results	have	
previously been described when comparing these tools in patients 
with cancer, emphasising the importance of differentiating between 
objective and subjective measures in cognitive assessments (Cull et 
al., 1996; Klepstad et al., 2002; Mystakidou, Tsilika, Parpa, Galanos, 
&	Vlahos,	2007).
The main strength of this study was that we applied several val‐
idated and internationally accepted tests to compare prospectively 
collected data about frailty in two relatively large cohorts of pa‐
tients with cancer. However, the study results should be inter‐
preted in the context of several limitations. For example, there was 
a need to merge the two different comorbidity scores, which may 
have led to inaccuracy in the analysis. Furthermore, the potential 
for	selection	bias	in	the	SO	cohort	may	have	affected	the	results.
Unfortunately,	we	were	also	unable	to	compare	data	regarding	
smoking and alcohol consumption because relevant data were miss‐
ing	in	the	SO	cohort.	Recent	literature	indicates	that	current	smok‐
ers have a greater than twofold increased risk of developing frailty 
compared	 with	 non‐smokers	 and	 former	 smokers	 (Kojima,	 Iliffe,	
Jivraj,	Liljas,	&	Walters,	2018).	Interestingly,	this	association	has	not	
been found for alcohol consumption, which may in fact be protective 
(Kojima	et	al.,	2019;	Kojima,	Liljas,	Iliffe,	Jivraj,	&	Walters,	2018).	We	
cannot exclude the possibility that a higher number of current smok‐
ers in the HNC cohort, if present, could have explained their higher 
frailty statuses.
A	final	limitation	of	the	study	is	the	lack	of	data	to	allow	compar‐
ison of nutritional statuses between the cohorts. BMI was the only 
available variable, and our results indicated that there were more 
underweight patients in the HNC cohort. Given that malnutrition is 
also associated with frailty, this finding may have contributed to the 





Patients with HNC had more impairments on multiple geriatric as‐
sessment	 and	QoL	measures	 than	patients	with	other	 solid	malig‐
nancies	(e.g.	MMSE,	TUG	and	global	QoL	and	emotional	functioning	
on	the	EORTC	QLQ‐C30).	However,	there	were	no	statistically	sig‐
nificant differences in comorbidity rates between cohorts. These 
findings confirm the previously held assertion that patients with 
HNC tend to be frailer than patients with other solid malignancies, 
emphasising the importance of proper geriatric assessments in HNC 
services.
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